A Phase 1b Study of Cetuximab and BYL719 (Alpelisib) Concurrent with Intensity Modulated Radiation Therapy in Stage III-IVB Head and Neck Squamous Cell Carcinoma
2020 ◽
Vol 106
(3)
◽
pp. 564-570
◽
2014 ◽
Vol 90
(1)
◽
pp. S535
2013 ◽
Vol 87
(2)
◽
pp. S469
2011 ◽
Vol 81
(2)
◽
pp. S545
2009 ◽
Vol 75
(3)
◽
pp. S386-S387
2010 ◽
Vol 78
(3)
◽
pp. S465
2013 ◽
Vol 87
(2)
◽
pp. S468-S469